Nexavar is a kinase inhibitor drug approved for the treatment of liver, kidney and thyroid cancer from Bayer.
Nexavar is dynamic, innovative and powerful sounding, with a confident/re-assuring tone, re-enforcing the key message of next-generation efficacy.
